| TTM
|
1/31/2026
|
1/31/2025
|
1/31/2024
|
1/31/2023
|
|
|---|---|---|---|---|---|
| Total Revenue
|
33,404,460 | 32,774,910 | 30,296,973 | 27,450,976 | 30,212,629 |
| Cost of Revenue
|
-28,115,300 | -27,548,250 | -25,291,307 | -22,647,301 | -24,685,713 |
|
Gross Profit
|
5,289,159 | 5,226,659 | 5,005,666 | 4,803,674 | 5,526,916 |
|
Operating Income/Expenses
|
-4,906,969 | -4,944,873 | -4,745,000 | -4,621,103 | -5,143,939 |
|
Total Operating Profit/Loss
|
382,190 | 281,786 | 260,666 | 182,571 | 382,977 |
| Total Net Finance Income/Expense
|
-3,222 | -1,908 | -8,983 | -7,679 | -10,789 |
| Net Investment Income
|
474 | 153 | -15,892 | 692 | 4,823 |
| Irregular Income/Expenses
|
-5,980 | -51,461 | -167,445 | -75,697 | -27,900 |
|
Other Income/Expense, Non-Operating
|
2,197 | 761 | -10,853 | -13,428 | -11,149 |
|
Non-Operating Income/Expenses, Total
|
-6,531 | -52,455 | -203,173 | -96,112 | -45,015 |
|
Pretax Income
|
375,663 | 229,332 | 57,493 | 86,461 | 337,961 |
| Provision for Income Tax
|
-118,916 | -80,689 | -60,026 | -61,184 | -130,736 |
|
Net Income from Continuing Operations
|
256,747 | 148,643 | -2,533 | 25,277 | 207,225 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
256,746 | 148,643 | -2,533 | 25,277 | 207,224 |
|
Non-Controlling/Minority Interests
|
361 | 2,087 | 6,700 | 5,084 | 10,961 |
|
Net Income after Non-Controlling/Minority Interests
|
257,106 | 150,730 | 4,166 | 30,362 | 218,186 |
|
Net Income Available to Common Stockholders
|
257,106 | 150,730 | 4,166 | 30,362 | 218,186 |
|
Diluted Net Income Available to Common Stockholders
|
257,106 | 150,730 | 4,166 | 30,362 | 218,186 |
| Basic EPS
|
9.30 | 5.45 | 0.15 | 1.10 | 8.00 |
| Diluted EPS
|
9.29 | 5.44 | 0.15 | 1.10 | 7.99 |
|
Basic Weighted Average Shares Outstanding
|
27,656.88 | 27,656.88 | 27,773.33 | 27,601.82 | 27,273.25 |
|
Diluted Weighted Average Shares Outstanding
|
27,704.23 | 27,704.23 | 28,687.50 | 27,601.82 | 27,310.51 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
378,885 | 231,240 | 66,476 | 94,140 | 348,750 |
|
EBITDA
|
548,628 | 403,551 | 250,794 | 265,330 | 512,627 |
|
Normalized EBITDA
|
554,148 | 454,871 | 433,787 | 340,863 | 539,639 |
|
Normalized Income
|
381,645 | 280,794 | 240,938 | 162,177 | 366,486 |
|
Total Unusual Items
|
5,520 | 51,320 | 182,993 | 75,533 | 27,012 |
|
Total Unusual Items Excluding Goodwill
|
5,520 | 51,320 | 182,993 | 75,533 | 27,012 |
|
Tax Effect of Unusual Items
|
1,747.36 | 18,064.64 | 42,454.38 | 17,523.66 | 10,453.64 |
1/31/2023 - 2/20/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade